53(top 5%)
papers
5.5K(top 2%)
citations
34(top 2%)
h-index
54(top 2%)
g-index
58
all documents
6.3K
doc citations
1.2K
citing journals

Top Articles

#TitleJournalYearCitations
1Whole genomes redefine the mutational landscape of pancreatic cancerNature20152,204
2Margin Clearance and Outcome in Resected Pancreatic CancerJournal of Clinical Oncology2009301
3Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker PanelJournal of Clinical Oncology2009281
4PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortalityInternational Journal of Cancer2010262
5Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancersProceedings of the National Academy of Sciences of the United States of America2010259
6Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialClinical Cancer Research2015211
7Hypermutation In Pancreatic CancerGastroenterology2017180
8DPC4/Smad4 Expression and Outcome in Pancreatic Ductal AdenocarcinomaJournal of Clinical Oncology2002154
9Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast CancerCancer Research2011153
10Cytoplasmic Localization of β-Catenin is a Marker of Poor Outcome in Breast Cancer PatientsCancer Epidemiology Biomarkers and Prevention2010141
11DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerNature Communications2015113
12Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationCell Reports2016111
13Low Microsatellite Instability Is Associated With Poor Prognosis in Stage C Colon CancerJournal of Clinical Oncology2005110
14miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS DefenseCancer Research2018109
15Clinical and molecular characterization of HER2 amplified-pancreatic cancerGenome Medicine2013101
16Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS ApproachPLoS ONE201591
17A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid CarcinomaAmerican Journal of Surgical Pathology201588
18Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic FeaturesAmerican Journal of Surgical Pathology201980
19Prognostic Significance of Pathologic Features in Localized Prostate Cancer Treated With Radical Prostatectomy: Implications for Staging Systems and Predictive ModelsJournal of Clinical Oncology200177
20Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 InhibitionCancer Research202172
21β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor ProgressionCancer Research201370
22Effects of Mechanical Stress and Carvedilol in Lamin A/C–Deficient Dilated CardiomyopathyCirculation Research201064
23Adjuvant chemotherapy in elderly patients with pancreatic cancerBritish Journal of Cancer201464
24ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor CellsPLoS Biology201560
25Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host InteractionPLoS ONE201158
26Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunitiesExpert Reviews in Molecular Medicine201553
27High Notch1 protein expression is an early event in breast cancer development and is associated with the HER‐2 molecular subtypeHistopathology201051
28ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotypeNature Communications201551
29Precision Oncology in SurgeryAnnals of Surgery202049
30ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumorsHuman Pathology201842
31Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal AdenocarcinomaClinical Cancer Research201433
32Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusScience Advances202131
33Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer—a potential diagnostic pitfallHistopathology200922
34TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-UpCancers202022
35MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast CancerInternational Journal of Radiation Oncology Biology Physics201518
36The epithelioid BAP1‐negative and p16‐positive phenotype predicts prolonged survival in pleural mesotheliomaHistopathology201817
37Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusInternational Journal of Cancer201016
38Gene Based Prediction of Clinically Localized Prostate Cancer Progression After Radical ProstatectomyJournal of Urology201015
39LRH-1 expression patterns in breast cancer tissues are associated with tumour aggressivenessOncotarget201714
40Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting With Hyperinsulinemic HypoglycemiaPancreas201611
41The Impact of Molecular Subtyping on Pathological Staging of Pancreatic CancerAnnals of Surgery202311
42LMO4 expression in squamous cell carcinoma of the anterior tongueHistopathology20119
43BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinomaPathology20189
44Messina: A Novel Analysis Tool to Identify Biologically Relevant Molecules in DiseasePLoS ONE20098
45Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesClinical Cancer Research20228
46The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal AdenocarcinomaDiseases (Basel, Switzerland)20187
47Individualizing therapy for pancreatic cancerJournal of Gastroenterology and Hepatology (Australia)20086
48Monoclonal precursor T-cell infiltrate in recurrent thymoma: a case reportPathology20152
49MCP‐1 expression in breast cancer and its association with distant relapseCancer Medicine20232
50LOSS OF ESTROGEN RECEPTOR-beta (ERbeta) IN PROSTATE CANCERPathology International20010